IMB Dx is Discovery Tools (Healthcare) in South Korea that focus on oncology technologies business. Founded in 2018. They cover business area such as precision, solution, safe and accurate cancer diagnosis, monitoring, blood sample test, various genetic variation, tumor dna, clinical service, gene mutation, cancer analysis, companion diagnosis, personalized information, patient, its progress, money.
2018
( 6 years old in 2024 )
Oncology Technologies
-
21st Floor, Building A
BYC High City Building, 131 Gasan Digital 1-ro
Seoul, Geumcheon-gu 08506
South Korea
Private
precisionsolutionsafe and accurate cancer diagnosismonitoringblood sample testvarious genetic variationtumor dnaclinical servicegene mutationcancer analysiscompanion diagnosispersonalized informationpatientits progressmoney
* We use standard office opening hours in near IMB Dx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
IMB Dx is Discovery Tools (Healthcare) business from South Korea that founded in 2018 (6 years old in 2024), IMB Dx business is focusing on Oncology Technologies.
IMB Dx headquarter office and corporate office address is located in 21st Floor, Building A BYC High City Building, 131 Gasan Digital 1-ro Seoul, Geumcheon-gu 08506 South Korea.
IMB Dx was founded in South Korea.
In 2024, IMB Dx is currently focus on oncology technologies sector.
Above is snippet of Google Trends for "oncology technologies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with IMB Dx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
